CSIMarket


Organicell Regenerative Medicine Inc   (BPSR)
Other Ticker:  
 
 

BPSR's Income from Cont. Operations Growth by Quarter and Year

Organicell Regenerative Medicine Inc 's Income from Cont. Operations results by quarter and year




BPSR Income from Cont. Operations (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter October - -5.16 -0.72 4.69
III Quarter July -1.41 -5.26 -0.35 -0.31
II Quarter April -2.24 -1.46 -0.42 -2.54
I Quarter January -8.15 -0.70 -0.24 -0.16
FY   -11.80 -12.58 -1.73 1.68



BPSR Income from Cont. Operations third quarter 2021 Y/Y Growth Comment
Organicell Regenerative Medicine Inc in the third quarter recorded loss from continued operations of $ -1.41 millions.

According to the results reported in the third quarter, Organicell Regenerative Medicine Inc achieved the best Income from Cont. Operations growth in Biotechnology & Pharmaceuticals industry. While Organicell Regenerative Medicine Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter.




BPSR Income from Cont. Operations ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter October - - - -
III Quarter July - - - -
II Quarter April - - - -
I Quarter January - - - -
FY   - - - -

Financial Statements
Organicell Regenerative Medicine Inc 's third quarter 2021 Income from Cont. Operations $ -1.41 millions BPSR's Income Statement
Organicell Regenerative Medicine Inc 's third quarter 2020 Income from Cont. Operations $ -5.26 millions Quarterly BPSR's Income Statement
New: More BPSR's historic Income from Cont. Operations Growth >>


BPSR Income from Cont. Operations (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter October - - - -
III Quarter July - - - -
II Quarter April - - - -
I Quarter January - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Organicell Regenerative Medicine Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BPSR's III. Quarter Q/Q Income from Cont. Operations Comment
Even if Organicell Regenerative Medicine Inc in the III. Quarter 2021 revealed loss from continued operations of $ -1.41 millions, management point out, that this are improvement compare to the -2.24 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Organicell Regenerative Medicine Inc achieved highest sequential Income from Cont. Operations growth. While Organicell Regenerative Medicine Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BPSR's III. Quarter Q/Q Income from Cont. Operations Comment
Even if Organicell Regenerative Medicine Inc in the III. Quarter 2021 revealed loss from continued operations of $ -1.41 millions, it should be mentioned, that this point to slight up side in contrast to the -2.24 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Organicell Regenerative Medicine Inc achieved highest sequential Income from Cont. Operations growth. While Organicell Regenerative Medicine Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Organicell Regenerative Medicine Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Jul 31 2021)
12 Months Ending
(Apr 30 2021)
12 Months Ending
(Jan 31 2021)
12 Months Ending
(Oct 31 2020)
12 Months Ending
(Jul 31 2020)
Cumulative Income from Cont. Operations 12 Months Ending $ -16.96 $ -20.81 $ -20.04 $ -12.58 $ -8.14
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Organicell Regenerative Medicine Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -17 millions in the Jul 31 2021 period.

Organicell Regenerative Medicine Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Organicell Regenerative Medicine Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -17 millions in the Jul 31 2021 period.

Organicell Regenerative Medicine Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
BPSR's Income from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for BPSR's Competitors
Income from Cont. Operations Growth for Organicell Regenerative Medicine Inc 's Suppliers
Income from Cont. Operations Growth for BPSR's Customers

You may also want to know
BPSR's Annual Growth Rates BPSR's Profitability Ratios BPSR's Asset Turnover Ratio BPSR's Dividend Growth
BPSR's Roe BPSR's Valuation Ratios BPSR's Financial Strength Ratios BPSR's Dividend Payout Ratio
BPSR's Roa BPSR's Inventory Turnover Ratio BPSR's Growth Rates BPSR's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Jul 31 2021 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Jul 31 2021
Lakeland Industries Inc -72.61%$ -72.609 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AYRO's Profile

Stock Price

AYRO's Financials

Business Description

Fundamentals

Charts & Quotes

AYRO's News

Suppliers

AYRO's Competitors

Customers & Markets

Economic Indicators

AYRO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071